Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The pill times 2: What every woman with multiple sclerosis should know.
Targeting human oligodendrocyte progenitors for myelin repair.
Multiple sclerosis and sexual dysfunction.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Reward responsiveness and fatigue in multiple sclerosis.
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
The translational biology of remyelination: Past, present, and future.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Simvastatin: a review.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Scrub typhus with longitudinally extensive transverse myelitis.
Diffusion Tensor Imaging (DTI) - A New Imaging Technique Applyed in Multiple Sclerosis.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.

Pages